Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock
Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), ...
Genpact director Lindstrom sells shares worth $267,430
Carol Lindstrom, a director at Genpact Ltd (NYSE:G), recently sold 4,916 common shares of the company on February 11, 2025. The shares were sold at a price of $54.40 per share, bringing the total ...